AGP Picks
View all

STEM News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.

Press releases published on September 8, 2026

BrainChild Bio Closes $116 Million Series A Financing
Vor Completes Enrollment of Global Phase 3 UPSTREAM MG Trial and Expands Telitacicept Global Franchise into Ocular Myasthenia Gravis
NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director
Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC
Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer
Newron Reports Subscription for EUR 5.5 Million of Shares by Investor Group as Part of Up to EUR 38 Million Total Financing to Advance Phase 3 Evenamide Program
DraftKings Extends Agreement with IC360 to Enhance Integrity Monitoring and Combat Athlete Harassment Across Sportsbook and Prediction Market Platforms
Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
Lahontan Strengthens Technical, Engineering, and Business Development Team
Silicon Motion to Attend Upcoming Investor Conferences
Rigetti Signs Definitive Agreement for $100M with U.S. Government to Accelerate R&D for Superconducting Quantum Computing
NRx Pharmaceuticals to Participate in Upcoming Investor Conferences
American Fusion Inc. (OTCQB: AMFN) Expands Intellectual Property Portfolio to 130 U.S. Patent Applications and Provides National Stock Exchange Uplisting and Capital Markets Update
X4 Pharmaceuticals Announces Positive Outcome from FDA Type C Meeting
OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference
BrewDog Roars into Rugby with Five-Year Leicester Tigers Partnership, Bringing Punk Energy to Welford Road
Global Enterprise Artificial Intelligence (AI) Market to Reach $206.6 Billion by 2031, Driven by Accelerating Cloud Infrastructure and Agentic AI Adoption
Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks
Prana Therapies Announces Positive Phase 1 Results for PRA-216, a Novel IL-4Rα/TSLP Bispecific Antibody, Supporting Its Potential Best-in-Disease Profile and Providing the First Clinical Validation of Prana’s INSPIRE Multispecific Platform

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

STEM News Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.